1. Microbiology and Infectious Disease
Download icon

Co-circulation of multiple influenza A reassortants in swine harboring genes from seasonal human and swine influenza viruses

  1. Pia Ryt-Hansen  Is a corresponding author
  2. Jesper Schak Krog
  3. Solvej Østergaard Breum
  4. Charlotte Kristiane Hjulsager
  5. Anders Gorm Pedersen
  6. Ramona Trebbien
  7. Lars Erik Larsen
  1. University of Copenhagen, Denmark
  2. Statens Serum Institut, Denmark
  3. Technical University of Denmark, Denmark
Research Article
  • Cited 3
  • Views 540
  • Annotations
Cite this article as: eLife 2021;10:e60940 doi: 10.7554/eLife.60940

Abstract

Since the influenza pandemic in 2009, there has been an increased focus on swine influenza A virus (swIAV) surveillance. This paper describes the results of the surveillance of swIAV in Danish swine from 2011 to 2018. In total, 3800 submissions were received with a steady increase in swIAV positive submissions, reaching 56% in 2018. Full genome sequences were obtained from 129 swIAV positive samples. Altogether, 17 different circulating genotypes were identified including six novel reassortants harboring human seasonal IAV gene segments. The phylogenetic analysis revealed substantial genetic drift and also evidence of positive selection occurring mainly in antigenic sites of the hemagglutinin protein and confirmed the presence of a swine divergent cluster among the H1pdm09Nx (clade 1A.3.3.2) viruses. The results provide essential data for the control of swIAV in pigs and emphasize the importance of contemporary surveillance for discovering novel swIAV strains posing a potential threat to the human population.

Data availability

All sequences generated in the study have been uploaded in NCBI GenBank with accession numbers MT666225 - MT667233, and will be released upon acceptance of the manuscript. All analyses of the sequences are included in the manuscripts or in the supplement files and figures.

Article and author information

Author details

  1. Pia Ryt-Hansen

    Department of Health Sciences, Institute for Animal and Veterinary Sciences, University of Copenhagen, Frederiksberg C, Denmark
    For correspondence
    piarh@sund.ku.dk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4819-6869
  2. Jesper Schak Krog

    Virus & Mikrobiologisk Specialdiagnostik, Statens Serum Institut, Copenhagen S, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  3. Solvej Østergaard Breum

    Virus & Mikrobiologisk Specialdiagnostik, Statens Serum Institut, Copenhagen S, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  4. Charlotte Kristiane Hjulsager

    Virus & Mikrobiologisk Specialdiagnostik, Statens Serum Institut, Copenhagen S, Denmark
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7557-8876
  5. Anders Gorm Pedersen

    Department of Health Technology, Section for Bioinformatics, Technical University of Denmark, Kongens Lyngby, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  6. Ramona Trebbien

    Virus & Mikrobiologisk Specialdiagnostik, Statens Serum Institut, Copenhagen S, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  7. Lars Erik Larsen

    Department of Health Sciences, Institute for Animal and Veterinary Sciences, University of Copenhagen, Frederiksberg C, Denmark
    Competing interests
    The authors declare that no competing interests exist.

Funding

Novo Nordisk Foundation (NNF19OC0056326)

  • Lars Erik Larsen

IDT Biologika GmbH (SwIAV surveillance)

  • Pia Ryt-Hansen
  • Jesper Schak Krog
  • Solvej Østergaard Breum
  • Charlotte Kristiane Hjulsager
  • Anders Gorm Pedersen
  • Ramona Trebbien
  • Lars Erik Larsen

Danish Veterinary and Food Administration (SwIAV surveillance)

  • Pia Ryt-Hansen
  • Jesper Schak Krog
  • Solvej Østergaard Breum
  • Charlotte Kristiane Hjulsager
  • Anders Gorm Pedersen
  • Ramona Trebbien
  • Lars Erik Larsen

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jos W Van der Meer, Radboud University Medical Centre, Netherlands

Publication history

  1. Received: July 10, 2020
  2. Preprint posted: July 29, 2020 (view preprint)
  3. Accepted: July 21, 2021
  4. Accepted Manuscript published: July 27, 2021 (version 1)
  5. Version of Record published: August 27, 2021 (version 2)

Copyright

© 2021, Ryt-Hansen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 540
    Page views
  • 102
    Downloads
  • 3
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Microbiology and Infectious Disease
    Anamaria Babosan et al.
    Research Article

    The plasmid-mediated quinolone resistance (PMQR) genes have been shown to promote high-level bacterial resistance to fluoroquinolone antibiotics, potentially leading to clinical treatment failures. In Escherichia coli, sub-minimum inhibitory concentrations (sub-MICs) of the widely used fluoroquinolones are known to induce the SOS response. Interestingly, the expression of several PMQR qnr genes is controlled by the SOS master regulator, LexA. During the characterization of a small qnrD-plasmid carried in E. coli, we observed that the aminoglycosides become able to induce the SOS response in this species, thus leading to the elevated transcription of qnrD. Our findings show that induction of the SOS response is due to nitric oxide (NO) accumulation in presence of sub-MIC of aminoglycosides. We demonstrated that the NO accumulation is driven by two plasmid genes, ORF3 and ORF4, whose products act at two levels. ORF3 encodes a putative flavin adenine dinucleotide (FAD)-binding oxidoreductase which helps NO synthesis, while ORF4 codes for a putative fumarate and nitrate reductase (FNR)-type transcription factor, related to an O2-responsive regulator of hmp expression, able to repress the Hmp-mediated NO detoxification pathway of E. coli. Thus, this discovery, that other major classes of antibiotics may induce the SOS response could have worthwhile implications for antibiotic stewardship efforts in preventing the emergence of resistance.

    1. Microbiology and Infectious Disease
    R Christopher D Furniss et al.
    Research Article

    Antimicrobial resistance in Gram-negative bacteria is one of the greatest threats to global health. New antibacterial strategies are urgently needed, and the development of antibiotic adjuvants that either neutralize resistance proteins or compromise the integrity of the cell envelope is of ever-growing interest. Most available adjuvants are only effective against specific resistance proteins. Here we demonstrate that disruption of cell envelope protein homeostasis simultaneously compromises several classes of resistance determinants. In particular, we find that impairing DsbA-mediated disulfide bond formation incapacitates diverse β-lactamases and destabilizes mobile colistin resistance enzymes. Furthermore, we show that chemical inhibition of DsbA sensitizes multidrug-resistant clinical isolates to existing antibiotics and that the absence of DsbA, in combination with antibiotic treatment, substantially increases the survival of Galleria mellonella larvae infected with multidrug-resistant Pseudomonas aeruginosa. This work lays the foundation for the development of novel antibiotic adjuvants that function as broad-acting resistance breakers.